logo

Motus Gi Holdings, Inc. (MOTS)



Trade MOTS now with
  Date
  Headline
3/27/2020 9:18:23 AM Motus GI Holdings Announces Receiving CE Mark Approval For The GEN2 Pure-Vu System
8/9/2019 7:12:10 AM Motus GI Q2 Net Loss $5.7 Mln Or $0.26 Per Share
3/27/2019 6:43:47 AM Motus GI 2018 Net Loss $22.3 Mln Or $1.47 Per Share
3/18/2019 8:12:59 AM Motus GI Announces Issuance Of New U.S. Patent For The Pure-Vu System
11/14/2018 7:36:18 AM Motus GI Q3 Net Loss $5.2 Mln Or $0.33/Shr
10/10/2018 8:10:28 AM Motus GI Presents Positive Clinical Data From U.S. Prospective Study Of The Pure-Vu® System
10/9/2018 12:05:15 PM Orchestra BioMed Adds Eric Rose, Jason Aryeh And Gary Pruden To Strategic Advisory Board
9/25/2018 7:01:32 AM Motus GI Names Timothy Moran To Assume Role Of CEO And Member Of Board
9/13/2018 8:04:24 AM Motus GI Gets FDA Clearance To Market Pure-Vu® Slim Sleeve For Use With Slim Colonoscopes
8/14/2018 8:07:27 AM Motus GI Q2 Net Loss $4.2 Mln Or $0.27 Per Share
5/15/2018 7:46:17 AM Motus GI Posts Q1 Net Loss Of $7.3 Mln Or $0.57 Per Share
4/16/2018 8:06:16 AM Motus GI Holdings Appoints Seth Gross To Its Medical Advisory Board
3/29/2018 7:10:31 AM Motus GI 2017 Net Loss $13.2 Mln Or $1.28 Per Share
3/27/2018 7:36:15 AM Motus GI Expands Intellectual Property Portfolio With New U.S. Patent Issuance For Pure-Vu System
3/20/2018 8:06:35 AM Motus GI Announces Issuance Of European Patent For Pure-Vu System